Literature DB >> 9269214

Effectiveness of needle-exchange programmes for prevention of HIV infection.

S F Hurley1, D J Jolley, J M Kaldor.   

Abstract

BACKGROUND: Needle-exchange programmes (NEPs) are potentially a key strategy for containing the spread of HIV infection among injecting drug users, but their implementation has been limited by uncertainty about their effectiveness. We used an ecological study design to compare changes over time in HIV seroprevalence in injecting drug users worldwide, for cities with and without NEPs.
METHODS: Published reports of HIV seroprevalence in injecting drug users were identified, and unpublished information on HIV seroprevalence for injecting drug users entering drug treatment in the USA between 1988 and 1993 was obtained from the Centers for Disease Control and Prevention. Details of the implementation of NEPs were obtained from published reports and experts. For each of the 81 cities with HIV seroprevalence data from more than 1 year and NEP implementation details, the rate of change of seroprevalence was estimated by regression analysis. The average difference in this rate for cities with and without NEPs was calculated.
FINDINGS: On average, seroprevalence increased by 5.9% per year in the 52 cities without NEPs, and decreased by 5.8% per year in the 29 cities with NEPs. The average annual change in seroprevalence was 11% lower in cities with NEPs (95% CI -17.6 to -3.9, p = 0.004).
INTERPRETATION: A plausible explanation for this difference is that NEPs led to a reduction in HIV incidence among injecting drug users. Despite the possibility of confounding, our results, together with the clear theoretical mechanisms by which NEPs could reduce HIV incidence, strongly support the view that NEPs are effective.

Entities:  

Mesh:

Year:  1997        PMID: 9269214     DOI: 10.1016/S0140-6736(96)11380-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  83 in total

1.  Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working?

Authors:  V D Hope; A Judd; M Hickman; T Lamagni; G Hunter; G V Stimson; S Jones; L Donovan; J V Parry; O N Gill
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

2.  Injection drug use and preventive measures: a comparison of Canadian and western European jurisdictions over time.

Authors:  B Fischer; J Rehm; T Blitz-Miller
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

3.  Changes in injection risk behavior associated with participation in the Seattle needle-exchange program.

Authors:  H Hagan; H Thiede
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

4.  The role of epidemiology in needle exchange programs.

Authors:  D Des Vlahov
Journal:  Am J Public Health       Date:  2000-09       Impact factor: 9.308

5.  Optimal placement of syringe-exchange programs.

Authors:  Amy Welton; Kurt Adelberger; Ken Patterson; David Gilbert
Journal:  J Urban Health       Date:  2004-06       Impact factor: 3.671

6.  Harmful microinjecting practices among a cohort of injection drug users in vancouver Canada.

Authors:  Beth Rachlis; Elisa Lloyd-Smith; Will Small; Diane Tobin; Dave Stone; Kathy Li; Evan Wood; Thomas Kerr
Journal:  Subst Use Misuse       Date:  2010-07       Impact factor: 2.164

7.  Survival of hepatitis C virus in syringes: implication for transmission among injection drug users.

Authors:  Elijah Paintsil; Huijie He; Christopher Peters; Brett D Lindenbach; Robert Heimer
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

8.  Do metropolitan HIV epidemic histories and programs for people who inject drugs and men who have sex with men predict AIDS incidence and mortality among heterosexuals?

Authors:  Samuel R Friedman; Brooke S West; Barbara Tempalski; Cory M Morton; Charles M Cleland; Don C Des Jarlais; H Irene Hall; Hannah L F Cooper
Journal:  Ann Epidemiol       Date:  2014-01-24       Impact factor: 3.797

Review 9.  The role of needle exchange programs in HIV prevention.

Authors:  D Vlahov; B Junge
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

10.  Consequences of a restrictive syringe exchange policy on utilisation patterns of a syringe exchange program in Baltimore, Maryland: Implications for HIV risk.

Authors:  Susan G Sherman; Shivani A Patel; Daesha V Ramachandran; Noya Galai; Patrick Chaulk; Chris Serio-Chapman; Renee M Gindi
Journal:  Drug Alcohol Rev       Date:  2015-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.